Dublin, Ireland

Chris Watson

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: University College Dublin. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chris Watson. Retrieved from https://idiyas.com/inventor/chris-watson-8daisrkc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cardiac Therapies by Chris Watson

Introduction

Chris Watson is an accomplished inventor based in Dublin, Ireland. He has made significant contributions to the field of cardiology through his innovative research and development of therapies for cardiomyopathy. His work focuses on improving treatment options for patients suffering from this serious heart condition.

Latest Patents

Chris Watson holds a patent for therapies aimed at treating cardiomyopathies. The present invention specifically addresses hypertrophic cardiomyopathy, a condition characterized by the thickening of the heart muscle. The therapeutic agents developed by Watson include hypomethylating agents, which have the potential to enhance treatment efficacy for affected individuals.

Career Highlights

Watson is affiliated with University College Dublin, where he conducts his research and collaborates with other experts in the field. His dedication to advancing cardiac therapies has positioned him as a key figure in medical innovation.

Collaborations

Some of his notable coworkers include John Baugh and Mark Ledwidge. Together, they work towards developing groundbreaking solutions for heart-related ailments.

Conclusion

Chris Watson's innovative work in the field of cardiomyopathy therapies exemplifies the impact of research and invention on healthcare. His contributions are paving the way for improved treatment options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…